Minerva Neurosciences Inc — 貸借対照表 (NASDAQ:NERV) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 57.63 M77.12 M55.09 M56.9 M37.14 M97.97 M 負債合計 4.96 M69.15 M75.11 M85.36 M62.84 M233.76 M 純資産合計 52.66 M7.98 M-20.02 M-28.46 M-25.69 M-140.75 M 負債および純資産合計 57.63 M77.12 M55.09 M56.9 M37.14 M97.97 M 有利子負債合計 —————— 純負債 ——————

ニュース

H.C. Wainwright、治験デザインを評価しMinerva Neurosciences目標株価を引き上げ

H.C. Wainwright raises Minerva Neurosciences price target on trial design

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript

ミネルバ・ニューロサイエンスが統合失調症専門家を取締役会に任命

Minerva Neurosciences appoints schizophrenia expert to board of directors

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences (NASDAQ:NERV)

ミネルバ・ニューロサイエンス株、2億ドルの資金調達で急騰

Minerva Neurosciences stock soars after securing $200 million financing

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - American Rebel Holdings (NASDAQ:AREB), Beyond Meat (NASDAQ:BYND)